Company Filing History:
Years Active: 2019
Title: Shingo Ogata: Innovator in Medical Chemistry
Introduction
Shingo Ogata is a prominent inventor based in Osaka, Japan. He is known for his contributions to the field of medical chemistry, particularly in the development of novel compounds for therapeutic use. His innovative work has led to significant advancements in the treatment of autoimmune diseases.
Latest Patents
Ogata holds a patent for "Imide derivatives and use thereof as medicine." This patent describes a novel low-molecular-weight compound that suppresses the production of induction type MMPs, particularly MMP-9, while not affecting the production of hemostatic type MMP-2. The compound is represented by a specific formula and has a selective MMP-9 production suppressive action. It is useful as a drug for the prophylaxis and/or treatment of autoimmune diseases such as rheumatoid arthritis, inflammatory bowel diseases like ulcerative colitis and Crohn's disease, as well as osteoarthritis. He has 1 patent to his name.
Career Highlights
Shingo Ogata is affiliated with Mitsubishi Tanabe Pharma Corporation, where he has made significant contributions to pharmaceutical research and development. His work focuses on creating effective treatments for various medical conditions, showcasing his dedication to improving patient outcomes.
Collaborations
Ogata has collaborated with notable colleagues, including Seigo Ishibuchi and Kunio Saruta. These partnerships have enhanced his research efforts and contributed to the success of his innovative projects.
Conclusion
Shingo Ogata's work in medical chemistry exemplifies the impact of innovation in healthcare. His patented compounds hold promise for treating serious autoimmune conditions, reflecting his commitment to advancing medical science.